Jian Xu, an assistant professor at the Children’s Medical Center Research Institute at UT Southwestern (CRI), received a Scholar Award from the Leukemia & Lymphoma Society (LLS). The award, which is highly selective, funds early-stage investigators who have demonstrated a strong track record in blood cancer-related research.
“I am very honored and grateful to receive the Scholar Award from The Leukemia & Lymphoma Society. Their support has played a critical role in advancing my career and allowed me to work at the frontiers of blood-cancer research. I truly appreciate the investment from LLS,” said Dr. Xu.
Dr. Xu and his lab will use this award to continue his research into myeloid leukemias, such as acute myeloid leukemia (AML), which remains one of the most difficult cancers to treat. The five-year survival rate for pediatric patients is 50%, and for adults, it is even lower.
“Although we’ve improved the cure rates in other childhood cancers, there is a critical and unmet need for developing improved therapies to treat AML and other blood cancers. This award will help our lab continue to study how cellular metabolism and epigenetic alterations control leukemia development which is not well understood currently. Discovering the link could help us find potentially curative therapies for the treatment of affected patients,” said Dr. Xu.
Learn more about Dr. Xu’s work and the LLS Scholar Award at the Leukemia & Lymphoma Society website.
